What does Dr. Van der Donckt Dirk - Dr. Opsomer Sophie do?

Dr. Van der Donckt Dirk - Dr. Opsomer Sophie is a specialist medical practice in Leuven. Private Limited, started on 13 July 2011, 1 establishment.

What is the address of Dr. Van der Donckt Dirk - Dr. Opsomer Sophie?

The registered office of Dr. Van der Donckt Dirk - Dr. Opsomer Sophie is located at Vinkenbosstraat 16, 3001 Leuven.

Is Dr. Van der Donckt Dirk - Dr. Opsomer Sophie still active?

Yes. According to the CBE (2 October 2026) Dr. Van der Donckt Dirk - Dr. Opsomer Sophie is active, legal situation “Normale toestand”, started on 13 July 2011.

Is Dr. Van der Donckt Dirk - Dr. Opsomer Sophie registered on Peppol?

Yes, Dr. Van der Donckt Dirk - Dr. Opsomer Sophie is registered on the Peppol network with ID 0208:0837850366.

What is the enterprise number of Dr. Van der Donckt Dirk - Dr. Opsomer Sophie?

The enterprise number of Dr. Van der Donckt Dirk - Dr. Opsomer Sophie is BE0837850366.

When was Dr. Van der Donckt Dirk - Dr. Opsomer Sophie founded?

Dr. Van der Donckt Dirk - Dr. Opsomer Sophie was founded on 13 July 2011.

Who are the directors of Dr. Van der Donckt Dirk - Dr. Opsomer Sophie?

According to the 2025 annual accounts, the directors of Dr. Van der Donckt Dirk - Dr. Opsomer Sophie are: Dirk Van Der Donckt , Sophie Marie Christine Opsomer.

Is Dr. Van der Donckt Dirk - Dr. Opsomer Sophie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 July 2011; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Dr. Van der Donckt Dirk - Dr. Opsomer Sophie make in 2025?

Dr. Van der Donckt Dirk - Dr. Opsomer Sophie posted a profit after taxes of € 442,717 in financial year 2025.

What is the revenue of Dr. Van der Donckt Dirk - Dr. Opsomer Sophie?

As a small company, Dr. Van der Donckt Dirk - Dr. Opsomer Sophie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 386,462.

Dr. Van der Donckt Dirk - Dr. Opsomer Sophie (Private Limited)

Dossier Dr. Van der Donckt Dirk - Dr. Opsomer Sophie, printed on 2 October 2026 from databakkes.be/en/0837850366/dr-van-der-donckt-dirk-dr-opsomer-sophie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Van der Donckt Dirk - Dr. Opsomer Sophie from Leuven, company number BE0837850366, closed financial year 2025 with a result of € 442,717 after tax. For that financial year Dr. Van der Donckt Dirk - Dr. Opsomer Sophie recorded a gross margin of € 386,462 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 215,651 to € 442,717. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Growing

€ 1.3 million

▲ 41% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 442,717

▲ 105% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 187,458

▼ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 73,933 paid out

17 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 50,797

▼ 39% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 6,286

▼ 85% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 29,813

▲ 31% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 302,946 Gross margin 2022: € 302,946 First fiscal year in the series	€ 320,801 Gross margin 2023: € 320,801 ▲ 6% vs 2022 (€ 302,946) Favourable step	€ 362,089 Gross margin 2024: € 362,089 ▲ 13% vs 2023 (€ 320,801) Favourable step	€ 386,462 Gross margin 2025: € 386,462 ▲ 7% vs 2024 (€ 362,089) Favourable step	▲ 7%
Profit after taxes	€ 184,026 Profit after taxes 2022: € 184,026 First fiscal year in the series	€ 182,950 Profit after taxes 2023: € 182,950 ▼ 1% vs 2022 (€ 184,026) Unfavourable step	€ 215,651 Profit after taxes 2024: € 215,651 ▲ 18% vs 2023 (€ 182,950) Favourable step	€ 442,717 Profit after taxes 2025: € 442,717 ▲ 105% vs 2024 (€ 215,651) Favourable step	▲ 105%
Equity	€ 650,973 Equity 2022: € 650,973 First fiscal year in the series	€ 760,212 Equity 2023: € 760,212 ▲ 17% vs 2022 (€ 650,973) Favourable step	€ 896,942 Equity 2024: € 896,942 ▲ 18% vs 2023 (€ 760,212) Favourable step	€ 1,265,726 Equity 2025: € 1,265,726 ▲ 41% vs 2024 (€ 896,942) Favourable step	▲ 41%
Total debts	€ 89,556 Total debts 2022: € 89,556 First fiscal year in the series	€ 25,872 Total debts 2023: € 25,872 ▼ 71% vs 2022 (€ 89,556) Favourable step	€ 70,672 Total debts 2024: € 70,672 ▲ 173% vs 2023 (€ 25,872) Unfavourable step	€ 36,147 Total debts 2025: € 36,147 ▼ 49% vs 2024 (€ 70,672) Favourable step	▼ 49%
Cash	€ 267,313 Cash 2022: € 267,313 First fiscal year in the series	€ 130,151 Cash 2023: € 130,151 ▼ 51% vs 2022 (€ 267,313) Unfavourable step	€ 217,697 Cash 2024: € 217,697 ▲ 67% vs 2023 (€ 130,151) Favourable step	€ 187,458 Cash 2025: € 187,458 ▼ 14% vs 2024 (€ 217,697) Unfavourable step	▼ 14%
Land & buildings	€ 219,166 Land & buildings 2022: € 219,166 First fiscal year in the series	€ 220,746 Land & buildings 2023: € 220,746 ▲ 1% vs 2022 (€ 219,166) Unchanged	€ 245,485 Land & buildings 2024: € 245,485 ▲ 11% vs 2023 (€ 220,746) Unchanged	€ 703,547 Land & buildings 2025: € 703,547 ▲ 187% vs 2024 (€ 245,485) Unchanged	▲ 187%
Retained profit	€ 644,773 Retained profit 2022: € 644,773 First fiscal year in the series	€ 754,012 Retained profit 2023: € 754,012 ▲ 17% vs 2022 (€ 644,773) Favourable step	€ 896,842 Retained profit 2024: € 896,842 ▲ 19% vs 2023 (€ 754,012) Favourable step	€ 1,265,626 Retained profit 2025: € 1,265,626 ▲ 41% vs 2024 (€ 896,842) Favourable step	▲ 41%
Dividend	€ 62,319 Dividend 2022: € 62,319 First fiscal year in the series	€ 73,710 Dividend 2023: € 73,710 ▲ 18% vs 2022 (€ 62,319) Unchanged	€ 72,821 Dividend 2024: € 72,821 ▼ 1% vs 2023 (€ 73,710) Unchanged	€ 73,933 Dividend 2025: € 73,933 ▲ 2% vs 2024 (€ 72,821) Unchanged	▲ 2%
Balance sheet total	€ 740,529 Balance sheet total 2022: € 740,529 First fiscal year in the series	€ 786,084 Balance sheet total 2023: € 786,084 ▲ 6% vs 2022 (€ 740,529) Unchanged	€ 967,614 Balance sheet total 2024: € 967,614 ▲ 23% vs 2023 (€ 786,084) Unchanged	€ 1,355,142 Balance sheet total 2025: € 1,355,142 ▲ 40% vs 2024 (€ 967,614) Unchanged	▲ 40%

Key figures of Dr. Van der Donckt Dirk - Dr. Opsomer Sophie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Van der Donckt Dirk - Dr. Opsomer Sophie?

What happened at Dr. Van der Donckt Dirk - Dr. Opsomer Sophie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: profit of € 442,717 (▲ 105% vs 2024). Source: NBB ↗
Jul 13, 2011 New establishment in Leuven. KBO
Jul 13, 2011 Start of the company according to the CBE. KBO

In short

From € 184,026 profit in 2022 to € 442,717 profit in 2025.

Paid € 353,122 in corporate taxes since 2022.

Best year ever: 2025, with € 442,717 profit.

Paid out € 282,784 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Van der Donckt Dirk - Dr. Opsomer Sophie? We notify you, reason included.

Follow Dr. Van der Donckt Dirk - Dr. Opsomer Sophie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Dirk Van Der Donckt Sophie Marie Christine Opsomer

Dr. Van der Donckt Dirk - Dr. Opsomer Sophie

Behind Dr. Van der Donckt Dirk - Dr. Opsomer Sophie are Dirk Van Der Donckt and Sophie Marie Christine Opsomer.

See the full network in the app

Directors

According to the 2025 annual accounts

Dirk Van Der Donckt

Director

Sophie Marie Christine Opsomer

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Vinkenbosstraat 16

3001 Leuven

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0837.850.366
VAT number: BE 0837.850.366
Registered office: Vinkenbosstraat 16, 3001 Leuven
Names & denominations: Dr. Van der Donckt Dirk - Dr. Opsomer Sophie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 13 July 2011
Peppol: Active · Active since 9 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗